Tuesday, February 9, 2010, 11:17pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Alexza Pharmaceuticals Inc. (ALXA)

 At 15:59 EST: 2.6705 USD  Up 0.0205 (0.77%)  
MORE ON ALXA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Alexza Pharmaceuticals, Inc. (NGM:ALXA) Delayed quote dataEdit
Last Trade: 2.6705 USD
Trade Time: 3:59PM EST
Change: Up 0.0205 (0.77%)
Prev Close: 2.65
Open: 2.63
Bid: 1.71 x 100
Ask: N/A
1y Target Est: 6.00
Day's Range: 2.59 - 2.7481
52wk Range: 1.40 - 3.25
Volume: 25,104
Avg Vol (3m): 105,214
Market Cap: 137.84M
P/E (ttm): N/A
EPS (ttm): -2.909
Div & Yield: N/A (N/A%)
Alexza Pharmaceuticals Inc. (ALXA)
1d  5d  3m  6m  1y  2y  5y 
 Add ALXA to Portfolio   Download Data

HEADLINES
• Coverage initiated on Alexza Pharma by WBB Securities
Briefing.com (Thu, Jan 28)
• Alexza Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
PRNewswire (Thu, Jan 28)
• Alexza Takes Big Step Forward
Zacks.com (Thu, Dec 17)
• Alexza Pharmaceuticals Inc. Announces Submission of AZ-004 NDA Call scheduled for 8:30 am ET today
CCBN (Tue, Dec 15)
• JA Solar, Array BioPharma: Early Volume Plays
at TheStreet.com (Tue, Dec 15)
• ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
EDGAR Online (Mon, Dec 14)
• Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
PRNewswire (Mon, Dec 14)
• Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
PRNewswire (Thu, Nov 19)
• ALEXZA PHARMACEUTICALS INC. Financials
EDGAR Online Financials (Sat, Nov 14)
• Alexza Pharmaceuticals Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Mon, Nov 9)
• ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 9)
More Headlines for ALXA...
ANALYST
EPS Est (next year) (Dec-09) : -2.54
EPS Est (in 2 years) (Dec-10) : -0.85
Avg Rec (current)*: 1.6
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Alexza Pharmaceuticals, Inc., a specialty pharmaceutical development stage company, focuses on the research, development, and commercialization of products for the acute treatment of central nervous system conditions.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices